Immunodominance and Functional Activities of Antibody Responses to Inactivated West Nile Virus and Recombinant Subunit Vaccines in Mice
- 1 March 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (5) , 1994-2003
Abstract
Factors controlling the dominance of antibody responses to specific sites in viruses and/or protein antigens are ill defined but can be of great importance for the induction of potent immune responses to vaccines. West Nile virus and other related important human-pathogenic flaviviruses display the major target of neutralizing antibodies, the E protein, in an icosahedral shell at the virion surface. Potent neutralizing antibodies were shown to react with the upper surface of domain III (DIII) of this protein. Using the West Nile virus system, we conducted a study on the immunodominance and functional quality of E-specific antibody responses after immunization of mice with soluble protein E (sE) and isolated DIII in comparison to those after immunization with inactivated whole virions. With both virion and sE, the neutralizing response was dominated by DIII-specific antibodies, but the functionality of these antibodies was almost four times higher after virion immunization. Antibodies induced by the isolated DIII had an at least 15-fold lower specific neutralizing activity than those induced by the virion, and only 50% of these antibodies were able to bind to virus particles. Our results suggest that immunization with the tightly packed E in virions focuses the DIII antibody response to the externally exposed sites of this domain which are the primary targets for virus neutralization, different from sE and isolated DIII, which also display protein surfaces that are cryptic in the virion. Despite its low potency for priming, DIII was an excellent boosting antigen, suggesting novel vaccination strategies that strengthen and focus the antibody response to critical neutralizing sites in DIII.Keywords
This publication has 62 references indexed in Scilit:
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyVirology, 2009
- Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibodyThe EMBO Journal, 2009
- The structural immunology of antibody protection against West Nile virusImmunological Reviews, 2008
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentCell Host & Microbe, 2008
- Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain IIJournal of Virology, 2008
- Molecular mechanisms of antibody-mediated neutralisation of flavivirus infectionExpert Reviews in Molecular Medicine, 2008
- Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus MacaquesJournal of Virology, 2006
- West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibodyProceedings of the National Academy of Sciences, 2006
- Isolation and Characterization of Human Monoclonal Antibodies from Individuals Infected with West Nile VirusJournal of Virology, 2006
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995